Small G W
Department of Psychiatry and Biobehavioral Sciences and the Center on Aging, University of California, Los Angeles (UCLA) School of Medicine; and the Veterans Affairs Medical Center, West Los Angeles, Calif, USA.
Dialogues Clin Neurosci. 2000 Sep;2(3):241-6. doi: 10.31887/DCNS.2000.2.3/gsmall.
Diagnosis of Alzheimer's disease is often missed or delayed in clinical practice; thus, methods to improve early detection would provide opportunities for early intervention, symptomatic treatment, and improved patient function. Emerging data suggest that the disease process begins years before clinical diagnostic confirmation. This paper reviews current research focusing on methods for more specific and sensitive early detection using measures of genetic risk for Alzheimer's disease and functional brain imaging. This approach aims to identify patients in a presymptomatic stage for early treatment to delay progressive cognitive decline and disease onset.
在临床实践中,阿尔茨海默病的诊断常常被漏诊或延误;因此,改善早期检测的方法将为早期干预、对症治疗和改善患者功能提供机会。新出现的数据表明,疾病进程在临床诊断确认前数年就已开始。本文综述了当前的研究,这些研究聚焦于利用阿尔茨海默病的遗传风险指标和功能性脑成像来进行更特异、更敏感的早期检测方法。这种方法旨在识别处于症状前阶段的患者以便进行早期治疗,从而延缓进行性认知衰退和疾病发作。